miRNA arrays

Using array-based miRNA profiles for individuals treated for prostate cancer, researchers identified 37 miRNA with differential expression in cases with recurrence.

NIH researchers have uncovered a blood-based microRNA signature that may be able to tell which patients with precursor disease may progress to myeloma.

The proof-of-principle application suggests networks of microRNA, RNA, and other 'omics data can untangle drug response and more.

NEW YORK (GenomeWeb) — Researchers interested in microRNA expression profiling today face a bevy of options including microarrays, quantitative PCR assays, and next-generation sequencing applications, but it is not always obvious which platform is the most suitable for a given study.

Exiqon continues to see demand for its microRNA microarray products, though its quantitative PCR assays and functional analysis products are driving its sales, according to its CEO Lars Kongsbak.

NEW YORK (GenomeWeb News) – A Medicare contractor has issued a final coverage determination confirming coverage for one of Rosetta Genomics' microRNA-based cancer diagnostics, but denying Medicare coverage for two of the firm's other tests, Rosetta announced today.

Rosetta Genomics has published a study describing the development and initial validation of its miRview Kidney test, a 24-microRNA array-based assay that classifies a patient's primary kidney tumor into one of four main subtypes.

With a handful of recently awarded grants, startup Circulomics is kicking off development of its technology as a tool for lower cost and more accessible multiplex analysis of disease-associated microRNAs, and is planning to launch its first kit, a 30-plex, semi-customizable cance

Affymetrix's latest offering to researchers studying microRNA continues to stand alone in the marketplace.

Three microRNAs have been implicated in the transformation of normal fibroblasts into cancer-promoting cells and could be potential drug targets in ovarian cancer, a study by University of Chicago and Northwestern University researchers has suggested.

Pages

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.